Featured Research

from universities, journals, and other organizations

Genetic Mutations Linked To Rare Metabolic Disease

Date:
March 8, 1999
Source:
Ohio State University
Summary:
Researchers have identified two mutations in a single gene as the cause of a very rare metabolic disease that affects people in Finland, Norway and Saudi Arabia. It has taken nearly 40 years since the identification of the disease for researchers to trace its cause back to a faulty gene.

COLUMBUS, Ohio -- Researchers have identified two mutations in a single gene as the cause of a very rare metabolic disease that affects people in Finland, Norway and Saudi Arabia. It has taken nearly 40 years since the identification of the disease for researchers to trace its cause back to a faulty gene.

An international team of a dozen scientists, including those from Ohio State University, reported their discovery in the latest issue of the journal Nature Genetics.

Called megaloblastic anemia 1, or Imerslund-Grasbeck syndrome after the two researchers who first described it, the defects prevent the normal absorption of vitamin B-12. If left untreated, the disease can be fatal. While serious, the syndrome is exceedingly rare -- only one person in a million may develop this disease. The disease has also been identified in patients from Israel, Turkey, Kuwait and the United States as well.

For this study, scientists mapped the DNA of 17 Finnish patients who had the disease, comparing it to disease-free control subjects. They also looked at DNA samples from patients in Norway, as well as members of a Bedouin family in Saudi Arabia, all of whom had the disease.

Researchers have known that the disorder was autosomally recessive, that is, it occurs only when a child inherits a bad copy of the gene from each parent. People who inherit a single bad gene are still able to metabolize vitamin B-12. Normally, vitamin B-12 binds to another compound in the body called intrinsic factor to form a chemical complex the body can use.

“But the gene mutation alters the three-dimensional structure of the protein cubilin that’s required to make that complex,” explains Ralf Krahe, an assistant professor of microbiology and immunology and a researcher with Ohio State’s Comprehensive Cancer Center.

“This is a very subtle change. It doesn’t completely destroy the protein -- it just changes a particular amino acid, proline, to leucine.”

The actual shape of protein molecules plays a major role in how they function. Proline normally causes a bend in the protein molecule at a specific place and in a specific direction. When the leucine was substituted for the proline, no bend was produced and the molecule malfunctioned.

This major Finnish mutation, called FM1, is responsible for 91 percent of the disease chromosomes studied during the project. The researchers also discovered a minor Finnish mutation, dubbed FM2, which, when the two are considered together, accounts for 97 percent of the mutant Finnish chromosomes. Both mutations are in the Cubilin (CUBN) gene.

Krahe, along with Maria Aminoff, a doctoral student from the University of Helsinki and visiting scientist at Ohio State, and Albert de la Chapelle, director of the Human Cancer Genetics Program at Ohio State, all believe that there is a third Finnish mutation -- FM3 -- waiting to be discovered.

This work on the genetic cause of megaloblastic anemia 1 was helped by the fact that it is more prevalent in Finland. Historically, the Finnish population has been isolated by geographic borders, Aminoff said. This confined these genetic mutations within a tight group of people.

At the same time, extensive medical and genealogical records are maintained by the Finnish government, and detailed marriage records are maintained by the church in that country. Together, these provide excellent tools for tracing the origin and spread of the gene mutations through the populations, she said. Krahe and his colleagues estimate the gene mutations began to spread as early as 1,000 to 1,300 years ago.

Along with the two identified Finnish mutations and the one that’s as yet undiscovered, the researchers believe that two other mutations in Norwegian patients may be linked to the disease and at least one mutation from the Bedouin family.

“That’s a total of six mutations in three distinct populations,” Krahe said.

Researchers from the University of Helsinki, the Minerva Foundation Institute for Medical Research in Helsinki, the National Guard King Khalid Hospital in Saudi Arabia, Vestfold Central Hospital in Norway, University of Aarhus in Denmark, and the Hospital Tenon in Paris participated in the study. Funding was provided by the Ulla Hjelt Fund, Liv och Halsa, the Academy of Finland and the National Cancer Institute.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Genetic Mutations Linked To Rare Metabolic Disease." ScienceDaily. ScienceDaily, 8 March 1999. <www.sciencedaily.com/releases/1999/03/990308054959.htm>.
Ohio State University. (1999, March 8). Genetic Mutations Linked To Rare Metabolic Disease. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/03/990308054959.htm
Ohio State University. "Genetic Mutations Linked To Rare Metabolic Disease." ScienceDaily. www.sciencedaily.com/releases/1999/03/990308054959.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins